45 related articles for article (PubMed ID: 32980749)
1. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.
Janmaat VT; Steyerberg EW; van der Gaast A; Mathijssen RH; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD004063. PubMed ID: 29182797
[TBL] [Abstract][Full Text] [Related]
2. Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review.
Zhang X; Zhou L; Zhou C; Shen L
Adv Ther; 2024 Jun; 41(6):2112-2132. PubMed ID: 38619719
[TBL] [Abstract][Full Text] [Related]
3. Palliative approach to leptomeningeal carcinomatosis in oesophagogastric junction cancer.
Cunha R; Godinho J; Inácio M; Galriça Neto I
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31604716
[TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab as a first-line treatment for advanced gastric cancer.
Chau I
Lancet Oncol; 2023 Nov; 24(11):1158-1159. PubMed ID: 37875145
[No Abstract] [Full Text] [Related]
5. Development, growth, and beyond.
Persson PB; Bondke Persson A
Acta Physiol (Oxf); 2023 Apr; 237(4):e13955. PubMed ID: 36815460
[No Abstract] [Full Text] [Related]
6. 2020 and Beyond.
Blackie M; Czerwiec MK
Lit Med; 2022; 40(2):229-234. PubMed ID: 38661882
[No Abstract] [Full Text] [Related]
7. Beyond "Can we?".
Dimitrov K; Jain SK; Olson APJ
J Hosp Med; 2024 Jan; 19(1):75-76. PubMed ID: 37792420
[No Abstract] [Full Text] [Related]
8. Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial.
Monti M; Morgagni P; Nanni O; Framarini M; Saragoni L; Marrelli D; Roviello F; Petrioli R; Fumagalli Romario U; Rimassa L; Bozzarelli S; Donini A; Graziosi L; De Angelis V; De Manzoni G; Bencivenga M; Mengardo V; Parma E; Milandri C; Mura G; Signorini A; Baiocchi G; Molfino S; Sgroi G; Steccanella F; Rausei S; Proserpio I; Viganò J; Brugnatelli S; Rinnovati A; Santi S; Ercolani G; Foca F; Valmorri L; Amadori D; Frassineti GL
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33003302
[TBL] [Abstract][Full Text] [Related]
9. Topical doxycycline monohydrate hydrogel 1% targeting proteases/PAR2 pathway is a novel therapeutic for atopic dermatitis.
Bohannon M; Liu M; Nadeau P; Talton J; Gibson D; Datta S; Schultz G; Talton J; De Benedetto A
Exp Dermatol; 2020 Dec; 29(12):1171-1175. PubMed ID: 32997843
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic Drug-drug Interaction of Antibiotics Used in Sepsis Care in China.
Yu X; Chu Z; Li J; He R; Wang Y; Cheng C
Curr Drug Metab; 2021; 22(1):5-23. PubMed ID: 32990533
[TBL] [Abstract][Full Text] [Related]
11. Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation.
Wada F; Nishikori M; Hishizawa M; Watanabe M; Aiba A; Kitano T; Shimazu Y; Shindo T; Kondo T; Takaori-Kondo A
Int J Hematol; 2020 Nov; 112(5):609-613. PubMed ID: 32980953
[TBL] [Abstract][Full Text] [Related]
12. Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study.
Pape M; Vissers PAJ; Dijksterhuis WPM; Bertwistle D; McDonald L; Mostert B; Derks S; Oving IM; Verhoeven RHA; van Laarhoven HWM
Ther Adv Med Oncol; 2023; 15():17588359231162576. PubMed ID: 36970109
[TBL] [Abstract][Full Text] [Related]
13. SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
Kuijper SC; Pape M; Haj Mohammad N; van Voorthuizen T; Verhoeven RHA; van Laarhoven HWM
Int J Cancer; 2023 Mar; 152(6):1202-1209. PubMed ID: 36451334
[TBL] [Abstract][Full Text] [Related]
14. Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer.
LaPelusa M; Shen C; Gillaspie EA; Cann C; Lambright E; Chakravarthy AB; Gibson MK; Eng C
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892891
[TBL] [Abstract][Full Text] [Related]
15. A population-based study in synchronous
Pape M; Vissers PAJ; Bertwistle D; McDonald L; Slingerland M; Haj Mohammad N; Beerepoot LV; Ruurda JP; Nieuwenhuijzen GAP; Jeene PM; van Laarhoven HWM; Verhoeven RHA
Ther Adv Med Oncol; 2022; 14():17588359221085557. PubMed ID: 35356260
[TBL] [Abstract][Full Text] [Related]
16. Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study.
Dijksterhuis WPM; Kalff MC; Wagner AD; Verhoeven RHA; Lemmens VEPP; van Oijen MGH; Gisbertz SS; van Berge Henegouwen MI; van Laarhoven HWM
J Natl Cancer Inst; 2021 Nov; 113(11):1551-1560. PubMed ID: 33837791
[TBL] [Abstract][Full Text] [Related]
17. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study.
Dijksterhuis WPM; Verhoeven RHA; Pape M; Slingerland M; Haj Mohammad N; de Vos-Geelen J; Beerepoot LV; van Voorthuizen T; Creemers GJ; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
Eur J Cancer; 2020 Nov; 139():107-118. PubMed ID: 32980749
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer: A Real-world Study.
Abdel-Rahman O; Mulder K; Easaw J
Am J Clin Oncol; 2021 Apr; 44(4):158-161. PubMed ID: 33625121
[TBL] [Abstract][Full Text] [Related]
19. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.
Haj Mohammad N; Bernards N; van Putten M; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
Eur J Cancer; 2017 Jun; 78():28-36. PubMed ID: 28412586
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
